Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


PSNC: We’ll use NHS 111 referrals to negotiate funding for walk-ins

PSNC will monitor the success of the NHS 111 referral service to negotiate remuneration for the possible increase in walk-in patients, its chief executive has said.

The Community Pharmacist Consultation Service (CPCS) – which launches across England on October 29 – will see pharmacies receive £14 for each consultation resulting from a referral from NHS 111 for minor illnesses and urgent medicines supply.

Pharmaceutical Services Negotiating Committee (PSNC) chief executive Simon Dukes said if an increasing number of patients are referred to pharmacy via NHS 111 – and possibly GP surgeries and urgent care, should the service be expanded as proposed in the five-year funding deal – it could lead to more patients “walking in, just to see the pharmacist”.

“If the consultation service is a success, which I really hope it will be…then people who have had a great service will think: ‘Well, why do I have to do that when I can just walk in?’,” he predicted at the Pharmacy Show in Birmingham on Sunday (October 6).

However, under the current contract for England, there is no remuneration for pharmacies managing walk-ins, which means they will not be paid for this additional workload, Mr Dukes added.

Once the CPCS launches, PSNC will be “capturing the data, to measure the baseline and increasing numbers of people walking in” and taking this information into its annual reviews of the contract with the Department of Health and Social Care (DH) and NHS England.

The increase in patient walk-ins “will happen, and then we need to find a way of remunerating appropriately as a result”, Mr Dukes told Pharmacy Show delegates.

Read C+D's analysis of how the five-year funding deal could affect your pharmacy

Do you think the CPCS will lead to an increase in walk-in patients to your pharmacy?

Related Content


Pharmacist Manager
£ Competitive

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts